Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Multiplex Assay Identifies Diarrheagenic Escherichia coli

By LabMedica International staff writers
Posted on 14 Aug 2014
A rapid, reliable and repeatable method is urgently needed for identifying diarrheagenic Escherichia coli (DEC) so as to provide the reference for responding to diarrheal disease outbreaks and the treatment of the diarrheal patients associated with DEC.

A multiplex real-time polymerase chain reaction (PCR) assay based multicolor-combinational probe coding (MCPC) for the identification of eight foodborne pathogens has been developed and applied to the rapid diagnosis of a foodborne disease outbreak successfully.

Molecular biologists at the Xiamen University (China) designed specific primers and modified molecular beacon probes of nine specific virulence genes, whose 5′ end were added with homo tail sequence. More...
They developed and optimized a two-tube modified molecular beacon based multiplex real-time PCR (rtPCR) assay for the identification of five Escherichia coli pathotypes.

A total of 102 bacterial strains, including 52 reference bacterial strains and 50 clinical strains, were isolated to confirm whether the target genes selected were specific. The detection limits of the assay were then tested. Lastly, the assay was applied to the detection of 11,860 clinical samples to evaluate the specificity and sensitivity of the developed assay compared with the conventional PCR. Multiplex rtPCR reactions were performed on the Bio-Rad CFX 96 Real-Time PCR System (Bio-Rad; Hercules, CA, USA).

The target genes were 100% specific as assessed on 102 bacterial strains since no cross-reactions were observed. The detection limits ranged from 88 colony forming units (CFU)/mL for Enterohemolysin E. coli (EHEC) to 880 CFU/mL Enteropathogenic E. coli (EPEC). Compared with the conventional PCR, the specificity and sensitivity of the multiplex rtPCR was 100% and over 99%, respectively. The coefficient of variation (CV) for each target gene ranged from 0.45% to 1.53%. Of the 171 positive clinical samples, 111 (64.9%) were identified as Enterotoxigenic E. coli (ETEC) and 38 (22.2%) as Enteropathogenic E. coli which were the dominating pathotypes of DEC strains.

The authors concluded that they had developed a rapid and effective two-tube multiplex rtPCR for the identification of all DEC pathotypes. This method took only 90 minutes and saved resources including biochemical reagents, disposable medical supplies and could be used in clinical and public health laboratories. The study was published on July 15, 2014, in the journal Annals of Clinical Microbiology and Antimicrobials.

Related Links:

Xiamen University
Bio-Rad



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.